We're excited to announce that Ovarian Cancer Action funded researchers Ahmed Ashour Ahmed & Prof Chris Yau Christopher Yau have been recognised by the Columbia Hospital For Women Research Foundation for publishing the most impactful paper in the field for 20/21.

Beyond proud to talk collaboration in ovarian cancer with the UK BioProcessing sector today. Thank you BioIndustry Association (BIA) for having me, Ahmed Ashour Ahmed , Jo Nunn, Dr Shibani Nicum and Sharon Grimster - the dream team 💪🏼

CIDER: an interpretable meta-clustering framework for single-cell RNA-seq data integration and evaluation: New paper by HU Zhiyuan with Ahmed Ashour Ahmed genomebiology.biomedcentral.com/articles/10.11…

Christmas Countdown Day 4 - The Oxford Classic arrives This year Nuffield Dept of Women's & Reproductive Health Ahmed Lab developed a new way to subtype ovarian #cancer called the #Oxford Classic. It enables accurate predictions of patient outcomes and dictate personalised therapies 👉cancer.ox.ac.uk/news/201cthe-o…

The early detection of disease seems like a good idea but why is it difficult to accomplish in practice? In this blog, I try to simply describe some methodological concepts that need to be considered in the context of early detection: cwcyau.github.io/post/earlydete…

Wonderful to see this Christopher Yau

A 3D microtumour system that faithfully represents ovarian cancer minimal residual disease biorxiv.org/cgi/content/sh… #bioRxiv

Really excited about this work in collaboration with Hagan Bayley group We built a credible model for minimal residual disease in ovarian cancer. An important step towards MRD elimination. A surprisingly under investigated topic in solid tumours.

Delighted that this prestigious fellowship is now available for applications in our lab in collaboration with Lincoln college

Huge congratulations to Prof Ahmed Ahmed for his distinguished service to academic obstetrics and gynaecology!👏👏👏

Christopher Yau Ahmed Ashour Ahmed University of Oxford While the possibilities are exciting, the integration of AI in personalised therapies brings new challenges. Regulatory considerations, potential biases, and the need for careful evaluation underscore the importance of thoughtful planning in AI-enabled therapeutic pathways.

AI is changing the way we approach cancer treatment. By analysing key data, #AI algorithms can see patterns and make predictions that help in developing treatments. Christopher Yau & Ahmed Ashour Ahmed explain more in The Physiological Society physoc.org/magazine-artic… #OvarianCancer #WomenHealthStudies

This #WorldCancerDay we’re taking a look at some of the ways our researchers are working to better understand cancers and how to treat and detect them 🔬🥼 Full video: youtu.be/iBuZDZnd73I We spoke to KJ Patel CAM-OX traveller, andi roy, Ahmed Ashour Ahmed and Ben Fairfax about their

What a great discovery Matteo Morotti the impact of this work on patients will be huge. Very well done

Great cancer prevention conference last week. Thank you Science and Innovation at Cancer Research UK for the opportunity to speak. It was very exciting and I learnt a lot Ahmed Ashour Ahmed

Promising! The world's first #ovariancancer vaccine OvarianVax could wipe the disease out - it teaches the immune system to recognize and attack the earliest stages of ovarian cancer. #Ovarcome University of Oxford Congratulations Ahmed Ashour Ahmed & team! 👏 news.sky.com/story/worlds-f…